Spotlight Obesity negatively impacts maintenance of antibody response to COVID-19 vaccines

Severe obesity accelerates the decline of neutralizing antibodies to COVID-19 vaccines contributing to increased risk of hospitalization from breakthrough SARS-CoV-2 infections.1 These findings have repercus-sion on the vaccination policy for SARS-CoV-2 variants and other infectious diseases like influenza in obese population.

Automated summary

Severe obesity speeds up the decline of neutralizing antibodies to COVID-19 vaccines, increasing the risk of hospitalization from breakthrough SARS-CoV-2 infections. These findings have implications for vaccination policies for SARS-CoV-2 variants and other infectious diseases like influenza in the obese population.